March 13, 2009 -Medical device pioneer Stentys said today it extended its self-expanding and disconnectable technology platform to include a second major indication - acute myocardial infarction (AMI). Two patients were successfully treated during AMI procedures last week by Drs. S. Verheye in Antwerp, Belgium and K. E. Hauptmann in Trier, Germany.

March 12, 2009 - CeloNova BioSciences Inc. said yesterday physicians performing a live stent implantation during the annual scientific meeting of the Sociedad Venezolana de Cardiologia Intervencionista (SOVECI), March 13-14, elected to use the CATANIA Coronary Stent System with NanoThin Polyzene-F to demonstrate the benefits of this innovative new stent technology.

March 10, 2009 - W. L. Gore & Associates today said the first clinical use of the GORE Flow Reversal System for neuroprotection during carotid artery stenting (CAS) was performed by Daniel McCormick, M.D. and Sheldon Goldberg, M.D., interventional cardiologists at Hahnemann University Hospital, Philadelphia.

March 11, 2009 - With the joint development of the Ziehm NaviPort 3D interface, the medical technology manufacturing companies Ziehm Imaging and Stryker have succeeded in importing 2D and 3D C-arm image data into Stryker’s active infrared navigation systems.

March 11, 2009 - Results from the PROTECT I trial evaluating the feasibility and effectiveness of the Abiomed Inc. Impella 2.5 circulatory assist device in high-risk percutaneous coronary intervention (PCI) procedures were published in the February issue of the Journal of the American College of Cardiology (JACC).

March 11, 2009 – The use of common screening tests, such as the ankle brachial index (ABI), along with traditional risk scoring systems like the Framingham Risk Score, has the potential to prevent heart attacks in thousands of individuals who, based on their Framingham, are not originally thought to be at high risk, say researchers at the Society of Interventional Radiology's 34th Annual Scienti

March 10, 2009 - Abbott today launched the VOYAGER NC Coronary Dilatation Catheter, a next-generation balloon dilatation catheter with high-pressure capability designed to optimize the treatment of patients with coronary artery disease (CAD) during angioplasty procedures. VOYAGER NC is now available in the U.S., Europe and select countries in Asia and Latin America.